CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-20 | Adawi Kamal Chief Financial Officer | Grant or award | +75,000 | 75,000 | ||
| 2025-10-20 | Adawi Kamal Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2025-08-04 | TAHL CINDY See Remarks | Sale | −9,037 | $1.06 | $10K | 397,670 |
| 2025-08-04 | Valamehr Bahram President and CEO | Sale | −14,466 | $1.06 | $15K | 334,898 |
| 2025-05-29 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | Xu Yuan Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | Mozaffarian Neelufar Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | MENDLEIN JOHN Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | EPSTEIN ROBERT S Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-05-29 | ABERNETHY MATT Director | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2025-05-29 | Agarwal Shefali Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-01-16 | Valamehr Bahram President and CEO | Grant or award · Stock Option (Right to Buy) | +1,300,000 | 1,300,000 | ||
| 2025-01-15 | TAHL CINDY See Remarks | Grant or award | +70,000 | 406,707 | ||
| 2025-01-15 | TAHL CINDY See Remarks | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-01-15 | Bressi Jerome Charles See Remarks | Grant or award | +65,000 | 335,203 | ||
| 2025-01-15 | Bressi Jerome Charles See Remarks | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2025-01-10 | Bressi Jerome Charles See Remarks | Sale | −5,980 | $1.55 | $9K | 270,203 |
Page 3 of 8 · 144 trades